Global Enteral Nutrition Market to Reach $21.1 Billion by 2030
The global market for Enteral Nutrition estimated at US$12.8 Billion in the year 2022, is projected to reach a revised size of US$21.1 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2022-2030. Liquid, one of the segments analyzed in the report, is projected to record 6.7% CAGR and reach US$16.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Powder segment is readjusted to a revised 5.4% CAGR for the next 8-year period.The U.S. Market is Estimated at $3.5 Billion, While China is Forecast to Grow at 11% CAGR
The Enteral Nutrition market in the U.S. is estimated at US$3.5 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5 Billion by the year 2030 trailing a CAGR of 11% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 5.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.Select Competitors (Total 43 Featured) -
- Abbott Laboratories
- Aveanna Healthcare, LLC
- B. Braun Holding GmbH & Co. KG
- Baxter International Inc.
- Danone Nutricia
- Fresenius Kabi AG
- Groupe Danone
- Halyard Health, Inc.
- Johnson & Johnson
- Medtronic Inc.
- Meiji Seika Pharma Co. Ltd.
- Nestle S.A.
- Nutricia
- Perrigo Company Plc
- Reckitt Benckiser Group Plc
- Shield HealthCare, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Aveanna Healthcare, LLC
- B. Braun Holding GmbH & Co. KG
- Baxter International Inc.
- Danone Nutricia
- Fresenius Kabi AG
- Groupe Danone
- Halyard Health, Inc.
- Johnson & Johnson
- Medtronic Inc.
- Meiji Seika Pharma Co. Ltd.
- Nestle S.A.
- Nutricia
- Perrigo Company Plc
- Reckitt Benckiser Group Plc
- Shield HealthCare, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 94 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 12.8 Billion |
Forecasted Market Value ( USD | $ 21.1 Billion |
Compound Annual Growth Rate | 6.4% |
Regions Covered | Global |